Enhabit, Inc. (NYSE:EHAB – Get Free Report) CAO Collin Mcquiddy sold 1,403 shares of the business’s stock in a transaction that occurred on Wednesday, March 11th. The shares were sold at an average price of $13.61, for a total transaction of $19,094.83. Following the transaction, the chief accounting officer directly owned 3,991 shares in the company, valued at $54,317.51. The trade was a 26.01% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Enhabit Stock Down 0.0%
Shares of NYSE:EHAB traded down $0.01 during trading on Thursday, reaching $13.62. 821,112 shares of the company traded hands, compared to its average volume of 1,372,830. The firm has a fifty day simple moving average of $11.39 and a 200 day simple moving average of $9.49. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.76. Enhabit, Inc. has a 1-year low of $6.47 and a 1-year high of $13.68. The firm has a market cap of $690.59 million, a P/E ratio of -151.28 and a beta of 1.56.
Enhabit (NYSE:EHAB – Get Free Report) last announced its quarterly earnings data on Wednesday, March 4th. The company reported $0.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.14. Enhabit had a positive return on equity of 4.71% and a negative net margin of 0.43%.The business had revenue of $270.40 million during the quarter, compared to analyst estimates of $270.56 million. Analysts anticipate that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Analyst Ratings Changes
EHAB has been the topic of a number of research reports. Oppenheimer downgraded Enhabit from an “outperform” rating to a “market perform” rating in a report on Monday, February 23rd. Deutsche Bank Aktiengesellschaft raised shares of Enhabit to a “buy” rating in a research report on Tuesday, January 13th. TD Cowen restated a “hold” rating and set a $13.80 price target (up from $12.00) on shares of Enhabit in a research note on Friday, March 6th. Wolfe Research set a $12.00 price objective on shares of Enhabit in a research note on Thursday, January 8th. Finally, Jefferies Financial Group cut shares of Enhabit from a “buy” rating to a “hold” rating and upped their price objective for the stock from $12.50 to $13.80 in a report on Monday, February 23rd. Two research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $13.57.
Read Our Latest Analysis on EHAB
About Enhabit
Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.
The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.
Recommended Stories
- Five stocks we like better than Enhabit
- America Is Losing the Mineral Arms Race With China. Trump Just Fired Back.
- The Forbes Mineral America Needs
- How China Accidentally Created Its Own Rare Earth Rival
- Gilder: Don’t Buy AI Stocks, Do This Instead
- The largest IPO in history is coming
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
